Blood Level Omega-3 Fatty Acids as Risk Determinant Molecular Biomarker for Prostate Cancer

被引:11
|
作者
Sorongon-Legaspi, Mishell Kris [1 ]
Chua, Michael [2 ]
Sio, Maria Christina [3 ]
Morales, Marcelino, Jr. [1 ]
机构
[1] St Lukes Coll Med, Dept Prevent & Community Med, Quezon City 1102, Philippines
[2] St Lukes Med Ctr, Inst Urol, 279 E Rodriguez Blvd,Cathedral Hts, Quezon City 1102, Philippines
[3] St Lukes Med Ctr, Dept Head Ear Neck & Throat, Quezon City 1102, Philippines
关键词
D O I
10.1155/2013/875615
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous researches involving dietary methods have shown conflicting findings. Authors sought to assess the association of prostate cancer risk with blood levels of omega-3 polyunsaturated fatty acids (n-3 PUFA) through a meta-analysis of human epidemiological studies in available online databases (July, 2012). After critical appraisal by two independent reviewers, Newcastle-Ottawa Quality Assessment Scale (NOQAS) was used to grade the studies. Six case control and six nested case control studies were included. Results showed nonsignificant association of overall effect estimates with total or advanced prostate cancer or high-grade tumor. High blood level of alpha-linolenic acid (ALA) had nonsignificant positive association with total prostate cancer risk. High blood level of docosapentaenoic acid (DPA) had significant negative association with total prostate cancer risk. Specific n-3 PUFA in fish oil, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) had positive association with high-grade prostate tumor risk only after adjustment of interstudy variability. There is evidence that high blood level of DPA that is linked with reduced total prostate cancer risk and elevated blood levels of fish oils, EPA, and DHA is associated with high-grade prostate tumor, but careful interpretation is needed due to intricate details involved in prostate carcinogenesis and N-3 PUFA metabolism.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Effect of omega-3 fatty acids on the incidence of cancer
    Wellbery, Caroline
    AMERICAN FAMILY PHYSICIAN, 2006, 74 (01) : 164 - 165
  • [32] Omega-3 fatty acids to augment cancer therapy
    Hardman, WE
    JOURNAL OF NUTRITION, 2002, 132 (11): : 3508S - 3512S
  • [33] Omega-3 Fatty Acids and Their Role in Pediatric Cancer
    Podpeskar, Alexandra
    Crazzolara, Roman
    Kropshofer, Gabriele
    Hetzer, Benjamin
    Meister, Bernhard
    Mueller, Thomas
    Salvador, Christina
    NUTRIENTS, 2021, 13 (06)
  • [34] Membrane modulatory effects of omega-3 fatty acids: Analysis of molecular level interactions
    Ayee, Manuela A. A.
    Bunker, Brendan C.
    De Groot, Jordan L.
    MEMBRANE BIOMECHANICS, 2020, 86 : 57 - 81
  • [35] Omega-3 fatty acids in colorectal cancer prevention
    Reddy, BS
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (01) : 1 - 7
  • [36] Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostate Cancer Risk
    Fradet, Vincent
    Cheng, Iona
    Casey, Graham
    Wittel, John S.
    CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2559 - 2566
  • [38] Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review
    Aucoin, Monique
    Cooley, Kieran
    Knee, Christopher
    Fritz, Heidi
    Balneaves, Lynda G.
    Breau, Rodney
    Fergusson, Dean
    Skidmore, Becky
    Wong, Raimond
    Seely, Dugald
    INTEGRATIVE CANCER THERAPIES, 2017, 16 (01) : 32 - 62
  • [39] Blood omega-3, but not trans, fatty acids are associated with risk for acute coronary syndromes
    Harris, WS
    Reid, KJ
    Spertus, JA
    CIRCULATION, 2006, 113 (08) : E341 - E341
  • [40] Omega-3 Fatty Acids can lower Blood Pressure
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (14) : 890 - 890